How drug companies are sidestepping the WHO's technology transfer hub in Africa
Pharmaceutical company Moderna announced on 7 March 2022 that it would develop a site in Kenya to manufacture COVID-19 vaccines. The company holds much of the key intellectual property relating to the messenger RNA (mRNA) ...
Mar 14, 2022
0
15